Legal Action for Reckitt Benckiser Group plc Shareholders
Class Action Notification for Reckitt Benckiser Group plc Shareholders
The Gross Law Firm wishes to inform shareholders of Reckitt Benckiser Group plc about an important class action lawsuit. This notice pertains to shareholders who acquired shares during a specified period.
Details of the Class Period
If you purchased shares between January 13, 2021, and July 28, 2024, you may have a claim. The firm encourages those affected to reach out regarding the potential for lead plaintiff appointments. Remember, you don’t need to be appointed as a lead plaintiff to benefit from any recovery.
Allegations and Claims
The allegations state that the company made significant misstatements regarding the safety of its cow's milk-based formula, Enfamil. These false statements reportedly misrepresented the risks associated with using this product, especially concerning preterm infants. As a result, Reckitt Benckiser's positive projections have come under scrutiny for being misleading.
Next Steps for Interested Shareholders
It's crucial for those eligible to register promptly for the class action. The deadline to register is August 4, 2025. Once registered, shareholders will have their information monitored throughout the lawsuit's progress. By registering, you will be kept informed about the class action’s status without incurring any costs.
About The Gross Law Firm
The Gross Law Firm aims to safeguard the rights of investors who have faced losses due to corporate misrepresentation or illegal practices. Their commitment is not only to seek justice for shareholders but also to promote ethical corporate behavior. Attorney advertising practices are in place to ensure that prior results do not guarantee future successes, maintaining transparency with interested parties.
Contact Information
For more details or inquiries, shareholders can contact:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the purpose of this class action lawsuit?
The lawsuit aims to address the alleged misleading statements made by Reckitt Benckiser Group plc concerning their product's safety, particularly its impact on vulnerable infants.
Who is eligible to participate in this class action?
Shareholders who purchased shares of Reckitt Benckiser Group plc during the class period from January 13, 2021, to July 28, 2024, can participate in the action.
How do I register for the class action lawsuit?
Interested shareholders should contact the Gross Law Firm to ensure they are registered before the deadline of August 4, 2025.
Is there a cost to participate?
No, there is no cost or obligation for shareholders to join the class action. Registration is free.
Why should I contact The Gross Law Firm?
The Gross Law Firm specializes in class action lawsuits and is dedicated to protecting the rights of investors against misleading corporate practices.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
